Time course of cytokine levels in sepsis

Intensive Care Medicine

Volumn 21, Issue 2 Supplement, 1995, Pages

  Thijs, L G ^a   Hack, C E ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CENTRAL LABORATORY   (Netherlands)

Author keywords

Cytokines; Mediators; Sepsis

Indexed keywords

INTERLEUKIN DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

BLOOD; HUMAN; IMMUNOLOGY; MORTALITY; MULTIPLE ORGAN FAILURE; PROGNOSIS; REVIEW; SEPSIS; TIME;

HUMANS; INTERLEUKINS; MULTIPLE ORGAN FAILURE; PROGNOSIS; SEPSIS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0000912790     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/BF01740764     Document Type: Article

References (31)

1. Association between tumour necrosis factor in serum and fatal out-come in patients with meningococcal disease
2. Tumor necrosis factor and interleukin 1 in the serum of children with severe infectious purpura
3. Plasma tumor necrosis factor levels in patients with presumed sepsis
4. Plasma tumor necrosis factor and mortality in critically ill patients
5. Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans
6. Prognostic values of tumor/cachectin, interleukin-1, interferon-α, and interferon-γ in the serum of patients with septic shock
7. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever
8. Plasma tumor necrosis factor in patients with septic shock
9. Dissociation between plasma and monocyte-associated cytokines during sepsis
10. Granulocyte elastase, tumor necrosis factor-α and urokinase levels as prognostic markers in severe infection
11. Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in gram-negative sepsis: relationship to endotoxin and cytokine levels
12. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality
13. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome
14. Release of soluble receptor for tumor necrosis factor in clinical sepsis and experimental endotoxemia
15. Prognostic values of serum cytokines in septic shock
16. Imbalance between tumor necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia
17. Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients
18. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity
19. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin-6, interleukin-1, and fatal outcome
20. Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease
21. Multiple forms of β2/IL-6 in serum and body fluids during acute bacterial infection
22. Increased plasma levels of interleukin-6 in sepsis
23. High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines
24. Soluble interleukin-6 (IL-6) receptor levels in septic patients and relation with circulating IL-6
25. Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 mRNA levels during septicemic and localized Pseudomonas pseudomallei infection
26. Interleukin-8 in sepsis: relation to shock and inflammatory mediators
27. Interleukin-8 in serum and cerbrospinal fluid from patients with meningococcal disease
28. High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome
29. Interleukin-10 production during septicaemia
30. Interleukin-10 protects mice against staphylococcal enterotoxin B-induced lethal shock
31. Interleukin-10 protects mice form lethal endotoxemia